G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.
β-arrestin1 (or arrestin2) and β-arrestin2 (or arrestin3) are ubiquitously expressed cytosolic adaptor proteins that were originally discovered for their inhibitory role in G protein-coupled receptor (GPCR) signaling through heterotrimeric G proteins. However, further biochemical characterization revealed that β-arrestins do not just "block" the activated GPCRs, but trigger endocytosis and kinase activation leading to specific signaling pathways that can be localized on endosomes. The signaling pathways initiated by β-arrestins were also found to be independent of G protein activation by GPCRs. The discovery of ligands that blocked G protein activation but promoted β-arrestin binding, or vice-versa, suggested the exciting possibility of selectively activating intracellular signaling pathways. In addition, it is becoming increasingly evident that β-arrestin-dependent signaling is extremely diverse and provokes distinct cellular responses through different GPCRs even when the same effector kinase is involved. In this review, we summarize various signaling pathways mediated by β-arrestins and highlight the physiologic effects of β-arrestin-dependent signaling.
Departments of *Medicine (Cardiology); and †Cell Biology, Duke University Medical Center, Durham, NC.
Pierre-Yves
PY
Jean-Charles
Suneet
S
Kaur
Sudha K
SK
Shenoy
D000818:Animals; D004705:Endocytosis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D000071557:beta-Arrestins / Q000378:metabolism* / Q000494:pharmacology
D043562:Receptors, G-Protein-Coupled; D000071557:beta-Arrestins